Novo Nordisk has requested the FDA to block manufacture of compounded copies of copyright, arguing that it’s as well tricky to do safely. It’s the latest escalation inside a brewing war involving pharmaceutical companies and compounders.They “essentially promote empty packaging, and any one can fill it,” he said. “It’s a business model